We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept
Products / CNS APIs
CNS APIs

CNS APIs

Inke develops and manufactures API ingredients for use in CNS therapies, as a subsidiary of Neuraxpharm,
a European leader in pharmaceutical products for the central nervous system (CNS)
API Indication Micronised / PSD CEP EU DMF US DMF JP DMF KR DMF CN DMF
Asenapine p Schizophrenia and acute mania
Brexpiprazole Schizophrenia and major depressive disorders
Brivaracetam Antiepileptic
Clomethiazole Insomnia
Eletriptan HBr p Migraine
Olanzapine p Schizophrenia, psychosis
Olanzapine pamoate (sterile) Schizophrenia, psychosis
Quetiapine hemifumarate p Schizophrenia, psychosis
Risperidone p Schizophrenia, psychosis
Rizatriptan benzoate p Migraine
Tetrabenazine Parkinson disease
Tetrabenazine (+) Parkinson disease
Zolmitriptan p Migraine
DOWNLOAD INKE APIs PRODUCT LIST

P = Patent applications/granted patents owned by Neuraxpharm

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.


© Neuraxpharm / INKE. All rights reserved.